, 2012), no reports to this point have examined the pharmacological properties of such K2 synthetic cannabinoids or their metabolites at CB2Rs. Consequently, the goal of this review was to ascertain the affinity and intrinsic activity of JWH-018, JWH-073 and a number of other of their major phas